To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
Archive | Essential MedicinesRSS feed for this section
The availability of a unified essential medicines list (EML) with evidence-based clinical efficacy to be used by the Ministry of Health (MOH) for the state-guaranteed package of services is an essential part of the successful launch of the health care reform initiative in Ukraine. This required the development and institutionalization of a process to ensure sustainability into the future rather than a one-off list of essential medicines. The main task of SIAPS was the provision of technical assistance to the Government of Ukraine to solve the problem of medicines list harmonization, which was needed to review and update the NEML to be the sole list for procurement or reimbursement with public funds, and to develop legislative documentation to institutionalize the process. The work was performed in cooperation with the MOH and the State Expert Center.
SIAPS provides technical assistance to the Inter-Ministerial Commission on Medicines Availability in Swaziland
Upon receiving an invitation from the Right Honourable Prime Minister of Swaziland, Dr Sibusiso Barnabas Dlamini, SIAPS provided technical assistance to the task team appointed to examine the problem of inconsistent availability of essential medicines. Recent media reports and routine assessments conducted by the SIAPS Program indicated frequent stock-outs of essential medicines and medicinal supplies, […]
This guide is designed to take country-level pharmaceutical and financing experts through the System of Health Accounts (SHA) framework as a potential approach that can be adapted to track pharmaceutical expenditures. The guide also reviews important first steps that must be considered to operationalize pharmaceutical expenditure tracking. It is intended to serve as a foundation for a wider conversation about pharmaceutical expenditure tracking approaches and to bring attention to key normative issues including expenditure definitions and boundaries that will need to be addressed before full-scale implementation guidelines for pharmaceutical expenditure tracking can be fully adopted.
By Abraham Ayuen, Senior Communications Specialist for SIAPS South Sudan. This post originally appeared on MSH’s website. Six-year-old Yohana Peter clutched a bottle of mango juice as he waited for his medication outside a pharmacy at Al Sabah Children’s Hospital in Juba, South Sudan. Seated next to his mother on a metal bench, Yohana looked anxious. […]
By Tsion Issayas, Communications Manager for SIAPS Ethiopia. This post originally appeared on MSH’s website. Aster Amanuel Desalegn lives in Debre Markos, 190 miles from the Ethiopian capital of Addis Ababa. She is a 70-year-old mother of four and grandmother of two. Her granddaughters, Emuye, 6, and Blen, 8, live with her. On a trip back […]
By Jane Briggs, Principal Technical Advisor More than 900,000 children die of pneumonia each year (more than malaria, measles, and HIV/AIDS combined), according to the World Health Organization. Many of these cases go undiagnosed and untreated. How can this be when we know what works? A five-day, twice-daily amoxicillin regimen—in either dispersible tablet (DT) or oral […]
Good Practices for the Dispensing of High-Cost Medicines in the Framework of an Integrated Supply System
Background Within the framework of health sector reform, the National Health Service (Servicio Nacional de Salud) of the Dominican Republic has been implementing the Integrated System for Medicine and Supply Management (Sistema Único de Gestión de Medicamentos e Insumos, or SUGEMI) in the public health services network. Its objective is to improve public access to […]
Promoting better use of medicines through the establishment of a National Essential Medicines Committee in Swaziland
The WHO estimates that more than 50% of all medicines are prescribed, dispensed or sold inappropriately, and that 50% of all patients fail to take them correctly. The overuse, underuse or misuse of medicines—also known as irrational use of medicines—results in wastage of scarce resources, increased risk of adverse drug reactions, and widespread health hazards, […]
Estrategias basadas en evidencia para la racionalización de la lista de medicamentos de alto costo en la Republica Dominicana
El Ministerio de Salud Pública (MSP) de República Dominicana organizó el Programa de Medicamentos de Alto Costo (PMAC) en 2008[i] con el propósito de facilitar atenciones clínicas a pacientes con patologías de muy baja prevalencia y alto costo de tratamiento, como cánceres refractarios a tratamientos convencionales, artritis reumatoide, hepatitis C y trasplante renal, entre otras. […]
The primary goal of the SIAPS TB Core portfolio was to ensure the availability of quality pharmaceutical products and support […]
- Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour […]
Project dates: September 2012 – December 2016